Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06689241
NA
Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
Sponsor: Alexandria University
View on ClinicalTrials.gov
Summary
Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial
Official title: Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Morbidly Obese Patients Undergoing Bariatric Surgery: An open_label Randomized Controlled Trial
Key Details
Gender
All
Age Range
20 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
162
Start Date
2024-10-01
Completion Date
2026-05-01
Last Updated
2025-04-22
Healthy Volunteers
Yes
Interventions
DRUG
Enoxaparin
40mg
DRUG
rivaroxaban
10mg
Locations (1)
Alexandria University
Alexandria, Egypt